Opinion
22-MC-0153 (JMF)
06-17-2022
TRACON PHARMACEUTICALS, INC., Movant, v. I-MAB BIOPHARMA, Respondent.
TRANSFER ORDER
JESSE M. FURMAN, UNITED STATES DISTRICT JUDGE
On June 16, 2022, Movant TRACON Pharmaceuticals, Inc., filed a letter consenting to the transfer of this case to the United States District Court for the District of Delaware and to the presiding judge in I-Mab Biopharma v. Inhibrx, Inc., No. 22-CV-0276 (D. Del.) pursuant to Rule 45(f) of the Federal Rules of Civil Procedure. See ECF No. 10. Accordingly, this case is hereby TRANSFERRED. All pending deadlines are moot. The Clerk of the Court is directed to transfer this case to the United States District Court for the District of Delaware immediately, without regard to Local Rule 83.1.
SO ORDERED.